Abstract Number: 2542 • ACR/ARHP Annual Meeting 2013
Michelle Petri1, Joan T. Merrill2, R. Maciuca3, John C. Davis Jr.3 and William P. Kennedy3, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Genentech, Inc, South San Francisco, CA
Background/Purpose: The SELENA flare index (SFI) has been used in clinical and clinical trial settings since 2005 (1), but has the limitation that it classifies…